Form D · Biotechnology
DYNAVAX TECHNOLOGIES CORP
Berkeley, CA · CIK 0001029142
Offering snapshot reported May 25, 2010 · SEC filing
- Reported sold
- $181K Offering amount: $181K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 11, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 25, 2010 | Initial | $181,000 | No comparison | 1 | SEC filing |
| Jan 7, 2010 | Initial | $20,067,480 | No comparison | 15 | SEC filing |
| Aug 1, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 28, 2006 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired, Other
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-142544
The exercise price of the warrant is $181,000.
Warrants to Purchase Common Stock and shares of underlying Common Stock.
Source: Form D, filed May 25, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Nancy L. Buc | Director |
| Francis R. Cano, Ph.D. | Director |
| Dennis Carson, M.D. | Director |
| Robert L. Coffman, Ph.D. | Executive |
| Dino Dina, M.D. | Director, Executive |
| Denise M. Gilbert, Ph.D. | Director |
| Zbigniew Janowicz, Ph.D. | Executive |
| Mark Kessel | Director |
| David M. Lawrence, M.D. | Director |
| Jennifer Lew | Executive |
| Arnold Oronsky, Ph.D. | Director |
| Michael S. Ostrach | Executive |
| Peggy V. Philips | Director |
| Stanley A. Plotkin, M.D. | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2929 Seventh Street Suite 100
Berkeley, CA, 94710
Berkeley, CA, 94710